LUCENTIS®
Indications

Lucentis is indicated in adults for:

  • The treatment of neovascular (wet) age-related macular degeneration (AMD)
  • The treatment of visual impairment due to diabetic macular edema (DME)
  • The treatment of proliferative diabetic retinopathy (PDR)
  • The treatment of visual impairment due to macular edema secondary to retinal vein occlusion (branch RVO or central RVO)
  • The treatment of visual impairment due to choroidal neovascularization (CNV)
LUCENTIS®

Package Insert

AMD - Age-related Macular Degeneration

DME - Diabetic Macular Edema
CNV - Choroidal Neovascularization
PDR - Proliferative Diabetic Retinopathy
RVO - Retinal Vein Occlusion
Rate this content: 
0
No votes yet
SG2308167841
×

Medical Information Request

×

Ask Speakers